Immunology
Conference Coverage
Crisaborole’s safety holds up in long-term atopic dermatitis trial
Key clinical point: The topical phosphodiesterase-4 inhibitor crisaborole was safe and well tolerated for up to 48 weeks in patients with mild-to-...
News
Yoga improves asthmatics’ quality of life, data review suggests
News
Azithromycin fails to ameliorate treatment-resistant cough
Key clinical point: This study did not support the clinical efficacy of low-dose macrolides for patients with treatment-resistant chronic cough....
News
Novel device therapy shows continued benefits in pediatric peanut allergy
Viaskin Peanut now in phase III testing after positive phase IIb extension study.
News
ED visits due to anaphylaxis doubled at Canadian children’s hospital
The percentage of emergency department (ED) visits due to anaphylaxis more than doubled from 2011 to 2015 at one Canadian children’s hospital.
News
Paperwork snarls stand between kids and at-school asthma medications
Four out of five children with asthma didn’t have access to their medication at school because the proper paperwork was missing, according to a...
Conference Coverage
Vitamin D supplementation cuts dust mite atopy
Key clinical point: Maternal treatment to achieve adequate vitamin D levels during late gestation followed by neonatal vitamin D supplementation...
Conference Coverage
Tiotropium inhalation spray effective for asthma regardless of allergic status
No need to define whether a patient has allergic or nonallergic asthma before prescribing Spiriva Respimat.
News
Sublingual immunotherapy for allergy-related asthma
Sublingual tablets containing house dust mite allergen immunotherapy extended the interval until a moderate or severe asthma exacerbation.
News
Atopic dermatitis early in childhood tied to increased risk of autism, ADHD
Conference Coverage
Cochrane Review nixes specific allergen immunotherapy for atopic dermatitis
Specific allergen immunotherapy “cannot be recommended for atopic eczema at present.”